OLUWASEUN TAOFEEK

Ms. OLUWASEUN TAOFEEK


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2021 in Heliyon
Verified
Journal Article
Open access
ARArise Rotimi
Arise Rotimi
OTOLUWASEUN TAOFEEK
OLUWASEUN TAOFEEK
KBKehinde Babaita
Kehinde Babaita
RARaphael Idowu Adeoye
Raphael Idowu Adeoye
OOOmorefosa Osemwegie
Omorefosa Osemwegie
Several novel functional peptides have been successfully extracted from plant storage proteins. This study investigated the degree of hydrolysis, peptide yield, amino acid constituents, angiotensin converting enzyme (ACE), alpha amylase inhibitory and in vitro antioxidant activities of cashew (Anarcardium occidentale) nut proteins (CNP) hydrolysates (CNPHs). Cashew nut proteins (albumin and globulin) were hydrolysed using pancreatin, Alcalase and trypsin. The peptide yield and degree of hydrolysis (DH) of CNP by pancreatin (75.69 ± 0.84%; 37.39 ± 0.31) was significantly higher than those by Alcalase (61.67 ± 0.55%; 23.87 ± 0.23) and trypsin (43.33 ± 0.45%; 11 ± 0.15). The inhibition of ACE by albumin and globulin hydrolysates was concentration dependent. At 1.2 mg/mL, ACE-inhibitory activity of pancreatic cashew nut globulin (CNGH) hydrolysate (51.65 ± 1.2%) was significantly higher than those of Alcalase (34.603 ± 0.65%) and tryptic (29.92 ± 0.73%) CNGHs. Cashew nut albumin hydrolysate (CNAH) demonstrated concentration-dependent alpha-amylase inhibition (IC50 0.17 ± 0.02–0.41 ± 0.021 mg/mL). The order of inhibition was tryptic > Alcalase > pancreatic CNAHs. The pancreatic hydrolysates of both albumin and globulin fractions displayed the highest DPPH antioxidant activity, while pancreatic CNAH was the most potent superoxide anion scavenger. These findings therefore posit that cashew nut globulin and albumin hydrolysates are laden with useful bioactive peptides that may be further explored for regulation of blood pressure and sugar in hypertensive and diabetic in vivo models.

1 January 2025 in Clinical and Experimental Vaccine Research
Verified
Journal Article
Open access
PDF file
OTOLUWASEUN TAOFEEK
OLUWASEUN TAOFEEK
SASolomon Osarumwense Alile
Solomon Osarumwense Alile
EEElcanah Mauta Evans
Elcanah Mauta Evans
LELouis Odinakaose Ezediuno
Louis Odinakaose Ezediuno
IGIfeoluwa Adeniyi George
Ifeoluwa Adeniyi George
LSLateef Adegboyega Sulaimon
Lateef Adegboyega Sulaimon
Taofeek OO, et al. Clin Exp Vaccine Res. 2025 Mar;14:e21. https://doi.org/10.7774/cevr.2025.14.e21

16 January 2024 in Journal of Umm Al-Qura University for Applied Sciences
Verified
Journal Article
Open access
PDF file
OTOLUWASEUN TAOFEEK
OLUWASEUN TAOFEEK
OOOlawale M. Oyewole
Olawale M. Oyewole
LSLateef A. Sulaimon
Lateef A. Sulaimon
SSSabur Olalekan Sanusi
Sabur Olalekan Sanusi
PAPrecious O. Akinnuoye
Precious O. Akinnuoye
FOFlorence T. Olorundare
Florence T. Olorundare
Abrus precatorius (AP) is a medicinal plant rarely studied for its beneficial effects against diabetes mellitus (DM) type-1. We estimated DM type-1 related parameters—total protein (TP), direct bilirubin (DB), urea, creatinine, alanine transaminase (ALT), aspartate transaminase (AST), alkaline phosphatase (ALP) and serum glucose (SG) after treatment with methanol extracts of AP leaves (APMLE) for 21 days, followed by histopathological analysis of kidney and liver sections. AP leaf bioactives (ALPBs) were collected from GCMS fractions, database, and literature; common targets were intersected with annotated DM type-1 genes from the experimental GSE14503 microarray dataset and genecard database. Overlapping differentially expressed genes were collected, and their protein–protein interaction network was analyzed using various bioinformatics tools: Enrichr, SRplot, GSEA, and Cytoscape, to provide insight into the potential molecular basis of APLBs in DM-type-1. 15 compounds were identified from GCMS analysis of APMLE. Antidiabetic potential of APMLE was observed with significant (p < 0.05) normalization of SG, TP, DB, ALT, AST, ALP, urea and creatinine while hepatorenal photomicrographs indicated moderate safety. Erucic acid, oleic acid, phytol and stigmasterol interacted with 25 type-1 DM biomarkers enriched in lipid and prostaglandin metabolic processes, neuroactive ligand receptor interaction, PPAR signaling pathway, diabetic cardiomyopathy, and cAMP signaling pathway. Furthermore, PPARalpha (peroxisome proliferator-activated alpha) and SCD (stearoyl-coenzyme A desaturase) were revealed as core biotargets interacting with APLBs via hydrogen bond, hydrophobic interaction, and van der Waals forces from the docking study. Future interests may provide additional experimental data into the mechanisms by which APLBs elicit this remarkable ability.

7 June 2020 in ScienceOpen Preprints
Verified
Preprint
Open access
PDF file
OTOLUWASEUN TAOFEEK
OLUWASEUN TAOFEEK
The novel severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) responsible for the 2019 coronavirus disease (COVID-19) has caused a global health challenge. The SARS-COV-2 main protease, 3CLpro/Mpro plays a critical role in the viral gene expression and replication and has been a major target for inhibiting viral maturation and enhancing host innate immune responses against COVID-19. In this study, we screened a library of 38 phytochemicals from Nigella sativa (blackseed), Trigonella foenum-graecum (Fenugreek) and Anona muricata (Soursop) potent medicinal plants with reported antiviral properties - in a molecular docking protocol on 3CLpro using Autodock4.0 tool implanted in PyRx followed by docking validation and insilico absorption, distribution, metabolism, excretion, and toxicology (ADMET) evaluations. The docking results were visualized using Accelrys Discovery Studio and Pymol software. Among the 38 ligands screened, 19 showed significant interaction through non-covalent hydrogen bonding, hydrophobic, and electrostatic interactions with binding affinities from -5.3kcal/mol to -8.1kcal/mol indicating significant binding interactions at the active site binding pocket. Another important interaction observed in the study which mostly involve the transfer of charges was pi-interactions such as Pi-Pi interaction, Pi-Alkyl interaction, Pi-Sulfur interaction, Pi- Sigma, and Pi-Pi stacking. The docking results revealed that phytochemicals from T. foenum-graecum showed more 3CLpro inhibitory potential compared to those from N. sativa and A. muricata. Insilico ADMET evaluations for drug-like and lead-like characteristics however demonstrated that only 8 ligands - apigenin, kaempferol, luteolin, dithymoquinone, naringenine, nornuciferine, quercetin and nigellidine were actually drug-like; showed best activities against 3CLpro, and lack hepatotoxicity effects while none was lead-like. Insilico results of this study further suggested that drug repurposing candidates, remdesivir, indinavir,hydroxychloroquine, chloroquine and ritonavir,exhibited various interactions with 3CLpro. Hence, further in vitro and in vivo studies are proposed.

23 April 2025 in bioRxiv
Verified
Preprint
Open access
PDF file
EEElcanah Mauta Evans
Elcanah Mauta Evans
OTOLUWASEUN TAOFEEK
OLUWASEUN TAOFEEK
TGTheresa Manful Gwira
Theresa Manful Gwira
CMCollins Misita Morang’A
Collins Misita Morang’A
TMThommas Musyoka
Thommas Musyoka
SNSteven Nyanjom
Steven Nyanjom
Human African Trypanosomiasis (HAT), caused by Trypanosome brucei , remains a critical health concern, with treatments such as Melarsoprol hampered by toxicity and resistance. To address this, we aimed to identify inhibitors targeting Trypanothione Reductase ( T.b TR), a key enzyme in the parasite’s survival. A pharmacophore model was derived from Melarsoprol and validated using Receiver Operating Characteristic (ROC) curves and Enrichment Factor (EF). Virtual screening of compound libraries identified two promising candidates, VS-1 and VS-2, based on superior docking scores. Subsequent molecular dynamics simulations confirmed the stability of the ligand-enzyme complexes, while binding free energy calculations revealed strong binding affinities for VS-1 and VS-2. Per-residue decomposition pointed critical interactions with active site residues, including MET 260, ASN 130, and HIS 128, contributing to the compounds’ stability and activity. These findings suggest that VS-1 and VS-2 are potential inhibitors of T.b TR, with better efficacy than Melarsoprol. However, further in vitro studies, including IC 50 determination, cell cycle analysis, and morphological assays, are essential to confirm the therapeutic potential of these compounds for the treatment of HAT.

14 January 2025 in medRxiv
Verified
Preprint
Open access
PDF file
OTOLUWASEUN TAOFEEK
OLUWASEUN TAOFEEK
SASolomon Osarumwense Alile
Solomon Osarumwense Alile
EEEvans Mauta Elcanah
Evans Mauta Elcanah
LELouis Odinakaose Ezediuno
Louis Odinakaose Ezediuno
IGIfeoluwa Adeniyi George
Ifeoluwa Adeniyi George
LSLateef Adegboyega Sulaimon
Lateef Adegboyega Sulaimon
Tuberculosis claims around 1.5 million lives annually. The M72/AS01E vaccine candidate is an innovative effort demonstrating a 50% reduction in the incidence of active TB in adults. However, optimization and effective immunization strategies against TB depends heavily on precise identification of specific molecular signatures active in vaccine protection. In this study, we employed weighted gene co-expression network analysis, machine learning and network biology to investigate the gene expression patterns of peripheral blood mononuclear cells, identifying transcriptomic markers of vaccine protection. Our comprehensive exploration of publicly available gene expression dataset comprising samples from subjects vaccinated twice with 10μg of M72/AS01E vaccine one day post-second dose (D31) and one week post-second dose (D37) in a Phase IIA clinical trial revealed intense induction of multiple gene modules, indicative of acute/immediate immune response at D31 that subsided by D37. Thirty-one hub genes with significant elevation/correlation with immune protection were identified significantly mediating key events in immunity to TB. The more selective profile at D37 involved additional adaptive immunity pathways including Th1/Th2/Th17 differentiation, T cell receptor and cytokine signaling. The functional relevance of these biomarkers in predicting vaccine response was further analyzed using the random forest classifier demonstrating high accuracy in distinguishing between vaccinated and non-vaccinated samples. Additionally, the study pinpointed a miRNAs-transcription factors (TF)-target regulatory network excavating key TF, miRNA, mRNAs mediating vaccine protection. Our results provided new insights into immune protection of M72/AS01E vaccine meriting further study aiming to advance its optimization and informing development of future TB vaccines.